[3] Vitetta is a professor of microbiology and immunology, the director of the Cancer Immunobiology Center, and holds both the Sheryle Simmons Patigian Distinguished Chair in Cancer Immunobiology and a distinguished teaching chair at the University of Texas Southwestern Medical Center in Dallas.
These innovative therapeutics have been extensively studied in tissue culture, animal models, and, since 1988, in over 300 human subjects.
[1] In 2001, Vitetta successfully developed a vaccine against ricin, which underwent evaluation in the first clinical trial of its kind.
She currently serves on the board of advisors of Scientists and Engineers for America, an organization focused on promoting sound science in American government.
Vitetta's former student, Linda Buck, won the Nobel Prize in Physiology or Medicine in 2004.